1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Syringes Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Smart Syringes Market Analysis and Forecast, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario by Region/Globally
5.3. Key Industry Events
5.4. Overview & Analysis of Smart Needles
5.5. Covid-19 Impact Analysis
6. Global Smart Syringes Market Analysis and Forecast, By Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type, 2017 – 2031
6.3.1. With Needle
6.3.1.1. Fixed
6.3.1.2. Exchangeable
6.3.2. Without Needle
6.4. Market Attractiveness By Type
7. Global Smart Syringes Market Analysis and Forecast, By Volume
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Volume, 2017 – 2031
7.3.1. Below 1000 µL
7.3.2. Above 1000 µL
7.4. Market Attractiveness By Volume
8. Global Smart Syringes Market Analysis and Forecast, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017 – 2031
8.3.1. Medical Use
8.3.1.1. Drug Delivery
8.3.1.2. Blood Sample Collection
8.3.1.3. Vaccination
8.3.2. Non-medical Use
8.4. Market Attractiveness By Application
9. Global Smart Syringes Market Analysis and Forecast, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Smart Syringes Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Type, 2017 – 2031
10.2.1. With Needle
10.2.1.1. Fixed
10.2.1.2. Exchangeable
10.2.2. Without Needle
10.3. Market Value Forecast By Volume, 2017 – 2031
10.3.1. Below 1000 µL
10.3.2. Above 1000 µL
10.4. Market Value Forecast By Application, 2017 – 2031
10.4.1. Medical Use
10.4.1.1. Drug Delivery
10.4.1.2. Blood Sample Collection
10.4.1.3. Vaccination
10.4.2. Non-medical Use
10.5. Market Value Forecast By Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Volume
10.6.3. By Application
10.6.4. By Country
11. Europe Smart Syringes Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017 – 2031
11.2.1. With Needle
11.2.1.1. Fixed
11.2.1.2. Exchangeable
11.2.2. Without Needle
11.3. Market Value Forecast By Volume, 2017 – 2031
11.3.1. Below 1000 µL
11.3.2. Above 1000 µL
11.4. Market Value Forecast By Application, 2017 – 2031
11.4.1. Medical Use
11.4.1.1. Drug Delivery
11.4.1.2. Blood Sample Collection
11.4.1.3. Vaccination
11.4.2. Non-medical Use
11.5. Market Value Forecast By Country/Sub-region, 2017 – 2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Volume
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Smart Syringes Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017 – 2031
12.2.1. With Needle
12.2.1.1. Fixed
12.2.1.2. Exchangeable
12.2.2. Without Needle
12.3. Market Value Forecast By Volume, 2017 – 2031
12.3.1. Below 1000 µL
12.3.2. Above 1000 µL
12.4. Market Value Forecast By Application, 2017 – 2031
12.4.1. Medical Use
12.4.1.1. Drug Delivery
12.4.1.2. Blood Sample Collection
12.4.1.3. Vaccination
12.4.2. Non-medical Use
12.5. Market Value Forecast By Country/Sub-region, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Volume
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Smart Syringes Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017 – 2031
13.2.1. With Needle
13.2.1.1. Fixed
13.2.1.2. Exchangeable
13.2.2. Without Needle
13.3. Market Value Forecast By Volume, 2017 – 2031
13.3.1. Below 1000 µL
13.3.2. Above 1000 µL
13.4. Market Value Forecast By Application, 2017 – 2031
13.4.1. Medical Use
13.4.1.1. Drug Delivery
13.4.1.2. Blood Sample Collection
13.4.1.3. Vaccination
13.4.2. Non-medical Use
13.5. Market Value Forecast By Country/Sub-region, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of LATAM
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Volume
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Smart Syringes Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017 – 2031
14.2.1. With Needle
14.2.1.1. Fixed
14.2.1.2. Exchangeable
14.2.2. Without Needle
14.3. Market Value Forecast By Volume, 2017 – 2031
14.3.1. Below 1000 µL
14.3.2. Above 1000 µL
14.4. Market Value Forecast By Application, 2017 – 2031
14.4.1. Medical Use
14.4.1.1. Drug Delivery
14.4.1.2. Blood Sample Collection
14.4.1.3. Vaccination
14.4.2. Non-medical Use
14.5. Market Value Forecast By Country/Sub-region, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle Eat & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Volume
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Agilent Technologies, Inc.
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Schott AG
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. Shimadzu Corporation
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Thermo Fisher Scientific Inc.
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Trajan LEAP PAL Parts + Consumables
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Clayens-np
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
